Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Soleno Therapeutics Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
SLNO
Nasdaq
8731
https://soleno.life/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Soleno Therapeutics Inc
Soleno Therapeutics Announces Pricing of Approximately $138 Million Public Offering Of Common Stock
- May 3rd, 2024 2:32 am
Soleno Therapeutics Announces Proposed Public Offering of Common Stock
- May 2nd, 2024 8:01 pm
Soleno Therapeutics Announces Peer-Reviewed Publication of Data Comparing DCCR Treatment to the Natural History of Prader-Willi Syndrome
- Apr 30th, 2024 12:00 pm
Why Soleno Therapeutics Stock Is Skyrocketing Today
- Apr 29th, 2024 3:11 pm
Soleno Therapeutics Receives Breakthrough Therapy Designation from U.S. FDA for DCCR (Diazoxide Choline) Extended-Release Tablets in Prader-Willi Syndrome (PWS)
- Apr 29th, 2024 12:00 pm
Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Apr 19th, 2024 8:05 pm
CEO Bhatnagar Anish Sells 18,980 Shares of Soleno Therapeutics Inc (SLNO)
- Apr 4th, 2024 5:54 am
Insider Sell: CFO James Mackaness Sells 5,175 Shares of Soleno Therapeutics Inc (SLNO)
- Apr 4th, 2024 5:54 am
We're Not Worried About Soleno Therapeutics' (NASDAQ:SLNO) Cash Burn
- Mar 11th, 2024 10:44 am
Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results
- Mar 6th, 2024 9:05 pm
Soleno Therapeutics to Present at the TD Cowen 44th Annual Health Care Conference
- Feb 22nd, 2024 1:00 pm
Soleno Therapeutics, Inc. (SLNO) Is a Great Choice for 'Trend' Investors, Here's Why
- Feb 14th, 2024 1:50 pm
Charter downgraded, Cigna upgraded: Wall Street's top analyst calls
- Feb 5th, 2024 3:10 pm
Soleno Therapeutics to Present at Upcoming February Investor Conferences
- Feb 1st, 2024 1:00 pm
Analysts Expect Breakeven For Soleno Therapeutics, Inc. (NASDAQ:SLNO) Before Long
- Jan 30th, 2024 12:46 pm
Here's Why Momentum in Soleno Therapeutics, Inc. (SLNO) Should Keep going
- Jan 26th, 2024 1:50 pm
Soleno Therapeutics Strengthens Leadership Team with Key Appointments
- Jan 24th, 2024 1:00 pm
Here's What Could Help Soleno Therapeutics, Inc. (SLNO) Maintain Its Recent Price Strength
- Jan 10th, 2024 1:50 pm
Why Soleno Therapeutics Stock Ticked Higher on Thursday
- Dec 21st, 2023 11:59 pm
Take Profit: 3 Stocks to Sell That Are Up More Than 200% in 2023
- Dec 14th, 2023 8:44 pm
Scroll